Protonix (Pantoprazole) Tablets for Acid Reflux
Protonix is an oral proton pump inhibitor containing pantoprazole. It is used in adults and children for gastro-oesophageal reflux disease, peptic ulcer disease and Zollinger-Ellison syndrome, and is often preferred when CYP2C19 drug interactions are a concern.
- Active ingredients
- Pantoprazole
- Manufacturer
- Pfizer
- Dosage forms
- delayed-release tablet, oral suspension
- Available dosages
- 20mg, 40mg
- Category
- Gastrointestinal Medications
What is it?
Protonix is the original brand of pantoprazole in the United States, marketed by Pfizer (originally by Wyeth). It was approved for clinical use in the late 1990s and is supplied as oral delayed-release tablets, oral suspension and parenteral solution. Protonix is dispensed both with and without prescription depending on dose and country. Multiple authorised generics are widely available.
Active ingredients
Each tablet contains pantoprazole (as the sodium sesquihydrate) as the sole active ingredient at 20mg or 40mg. Pantoprazole is a substituted benzimidazole proton pump inhibitor with a weaker effect on CYP2C19 than omeprazole or esomeprazole at therapeutic doses.
Forms and dosages
Protonix is administered orally once daily, with or without food. According to the prescribing information, the usual adult dose is 40mg once daily for erosive oesophagitis healing or peptic ulcer healing, with maintenance doses of 20-40mg once daily. Higher doses are used in Zollinger-Ellison syndrome. Tablets should be swallowed whole with water and should not be crushed or chewed.
Indications
Protonix is approved in adults and children for the treatment of gastro-oesophageal reflux disease, including erosive oesophagitis healing and maintenance, peptic ulcer disease, prevention of NSAID-induced ulcers, Zollinger-Ellison syndrome and as part of triple-therapy regimens for Helicobacter pylori eradication. According to clinical guidelines, the lowest effective dose for the shortest necessary duration should be used, with periodic reassessment of long-term therapy.
How it works
Pantoprazole is a substituted benzimidazole prodrug activated in the acidic environment of the gastric parietal cell, where it irreversibly inhibits the H+/K+-ATPase enzyme — the proton pump responsible for the final step in gastric acid secretion. Acid secretion gradually returns after discontinuation as new pumps are synthesised. Compared with omeprazole and esomeprazole, pantoprazole is a weaker inhibitor of CYP2C19.
Frequently asked questions
Why is Protonix preferred in patients on clopidogrel? ▾
Pantoprazole is a weaker inhibitor of CYP2C19 than omeprazole and esomeprazole at therapeutic doses, so it has less effect on the activation of the antiplatelet prodrug clopidogrel. According to several regulatory communications and clinical guidelines, when a proton pump inhibitor is needed in a patient on clopidogrel, Protonix is generally preferred over Prilosec or Nexium. The choice should be made by the prescriber.
How is Protonix different from Prilosec? ▾
Both are substituted benzimidazole proton pump inhibitors with similar acid-suppressive efficacy at equivalent doses. Pantoprazole has higher oral bioavailability (around 77% vs 30-40%), more food-independent absorption and weaker CYP2C19 inhibition than omeprazole. Choice between the two depends on the clinical context, drug interactions and the prescriber's judgement, with both supported by international guidelines.
When should Protonix be taken? ▾
Protonix is most effective when taken approximately 30 to 60 minutes before a meal, ideally before breakfast, because the proton pumps are most active during meals. According to the prescribing information, tablets should be swallowed whole with water and not crushed or chewed, because the enteric coating protects the active drug from gastric acid degradation. Oral suspension formulations have specific reconstitution instructions.
Can Protonix be taken long-term? ▾
Protonix is commonly used for prolonged periods in chronic GORD, Barrett's oesophagus and peptic ulcer prophylaxis with NSAIDs. Long-term use has been associated with potential reductions in vitamin B12 and magnesium absorption, an increased risk of bone fractures and possible enteric infections. According to international guidelines, long-term proton pump inhibitor therapy should be regularly reassessed, with the lowest effective dose used.
What are the main contraindications for Protonix? ▾
Protonix is contraindicated in known hypersensitivity to pantoprazole or substituted benzimidazoles, and in concurrent use with rilpivirine. Caution is required in severe hepatic impairment, in long-term use with monitoring of magnesium and bone density, and during pregnancy and breastfeeding. According to the prescribing information, the medical history must be reviewed by a clinician before any prescription.
Related medications
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.